Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

ClinicalTrials.gov ID: NCT07676565

Public ClinicalTrials.gov record NCT07676565. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 16, 2026, 6:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Adjunct Therapies in Adults With Type 1diabetes: Multicenter, Registry Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This will be a multicenter registry-based study to evaluate safety and efficacy of GLP-1RA and SGLTi therapies in adjunct to insulin in adults with type 1 diabetes (T1D) over 1 year. This study will enroll participants who have been prescribed adjunct therapy as part of usual care.

Study identification

NCT ID: NCT07676565
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Indiana University; Other
Enrollment: 300 participants

Conditions and interventions

Conditions

Type 1 Diabetes

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 24, 2026 (Actual)
Primary completion: Apr 2028 (Estimated)
Completion: Apr 2028 (Estimated)
Last update posted: Oct 16, 2026

2026 – 2028

United States locations

U.S. sites: 17
U.S. states: 13
U.S. cities: 16

Facility	City	State	ZIP	Site status
Hoag Memorial Hospital	Newport Beach	California	92663	Recruiting
University of California, San Francisco (UCSF)	San Francisco	California	94158	Recruiting
University of Miami	Miami	Florida	33136	Recruiting
Emory University	Atlanta	Georgia	30303	Recruiting
Northwestern University	Chicago	Illinois	60611	Recruiting
University of Louisville	Louisville	Kentucky	40202	Recruiting
Maine Health Research Institute	Portland	Maine	04102	Recruiting
Harvard Medical School	Boston	Massachusetts	02115	Recruiting
Henry Ford Hospital	Detroit	Michigan	48202	Recruiting
HealthPartners, International Diabetes Center	Minneapolis	Minnesota	55416	Recruiting
University of Nebraska Medical Center	Omaha	Nebraska	68198	Recruiting
NYU Grossman School of Medicine	New York	New York	10016	Recruiting
Mount Sinai	New York	New York	10029	Recruiting
University of Rochester	Rochester	New York	14642	Recruiting
University of Cincinnati	Cincinnati	Ohio	45267	Recruiting
Ohio State University	Columbus	Ohio	43203	Recruiting
Eastern Virginia Medical Center, Old Dominion University	Norfolk	Virginia	23510	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07676565, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 16, 2026 · Synced Oct 16, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07676565 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →